NCT03191162View on ClinicalTrials.gov

Evaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease.

PHASE2CompletedINTERVENTIONAL
Enrollment

238

Participants

Timeline

Start Date

April 21, 2017

Primary Completion Date

September 21, 2020

Study Completion Date

March 16, 2021

Conditions
Chagas DiseaseTrypanosoma Cruzi Infection
Interventions
DRUG

Benznidazole

To evaluate different regimens of Benznidazole for the treatment of chronic Chagas disease

Trial Locations (7)

Unknown

Instituto Nacional de Parasitología Dr. Mario Fatala Chaben (ANLIS), Buenos Aires

Instituto de Cardiología de Corrientes Juana Francisca Cabral, Corrientes

Centro de Pesquisas René Rachou - Fundação Oswaldo Cruz. (FIOCRUZ), Belo Horizonte

Hospital Universitário Clemente de Faria, Montes Claros

Fundación Cardioinfantil - Instituto de Cardiología, Bogotá

Centro Atencion y Diagnóstico de Enfermedades Infecciosas, Bucaramanga

Infectious Disease Department Vall d'Hebron Hospital, Barcelona

All Listed Sponsors
lead

Hospital Universitari Vall d'Hebron Research Institute

OTHER

NCT03191162 - Evaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease. | Biotech Hunter | Biotech Hunter